Publications

A systematic strategy for estimating hERG block potency and its implications in a new cardiac safety paradigm. “Bradley J. Ridder, Derek J. Leishman, Matthew Bridgland-Taylor, Mohammadreza Samieegohar, Xiaomei Han, Wendy W. Wu, Aaron Randolph, Phu Tran, Jiansong Sheng, Timm Danker, Anders Lindqvist, Daniel Konrad, Simon Hebeisen, Liudmila Polonchuk, Evgenia Gissinger, Muthukrishnan Renganathan, Bryan Koci, Haiyang Wei, Jingsong Fan, Paul Levesque, Jae Kwagh, John Imredy, Jin Zhai, Marc Rogers, Edward Humphries, Robert Kirby, Sonja Stoelzle-Feix, Nina Brinkwirth, Maria  Giustina Rotordam, Nadine Becker, Søren Friis, Markus Rapedius, Tom A. Goetze, Tim Strassmaier, George Okeyo, James Kramer, Yuri Kuryshev, Caiyun Wu, Herbert Himmel, Gary R. Mirams, David G. Strauss, Rémi Bardenet, Zhihua Lia. Toxicology and Applied Pharmacology, 394: 114961

Cross-site and cross-platform variability of automated patch clamp assessments of drug effects on human cardiac currents in recombinant cells.  Kramer, J.; Himmel, H. M.; Lindqvist, A.; Stoelzle-Feix, S.; Chaudhary, K. W.; Li, D.; Bohme, G. A.; Bridgland-Taylor, M.; Hebeisen, S.; Fan, J.;  Renganathan, M.;  Imredy, J.; Humphries, E. S. A.; Brinkwirth, N.; Strassmaier, T.; Ohtsuki, A.; Danker, T.; Vanoye, C.; Polonchuk, L.; Fermini, B.; Beck Pierson, J.;  Gintant, G. Scientific Reports, 2020, 10; 5627

Ion channel drug discovery and modern medicine. Rogers, M.  MedNous, November-December 2019. Article published in the November-December 2019 edition of ‘MedNous’, a publication of Evernow Publishing Ltd.

The role of Nav1.7 in human nociceptors: insights from human induced pluripotent stem cell-derived sensory neurons of erythromelalgia patients. Meents, J.E.; Bressan, E.; Sontag, S.; Foerster, A.; Hautvast, P.; Rösseler, C.; Hampl, M.; Schüler, H.; Goetzke, R.; Le TKC.; Kleggetveit, I.P.; Le Cann, K.; Kerth, C.; Rush, A.M.; Rogers, M.; Kohl, Z.; Schmelz, M.; Wagner, W.; Jørum, E.; Namer, B.; Winner, B.; Zenke, M.; Lampert, A. PAIN, March 22, 2019 – Article in Press

Recent advances in targeting ion channels to treat chronic pain. Stevens, E.B.; Stephens, G.J.  British Journal of Pharmacology. 2018, 175 (12), 2133-2137

Clathrodin, hymenidin and oroidin, and their synthetic analogues as inhibitors of the voltage-gated potassium channels.  Zidar, N.; Žula, A.; Tomašič, T.; Rogers, M.; Kirby, RW.; Tytgat, J.; Peigneur, S.; Kikelj, D.; Ilaš, J.; Mašič LP.  European Journal of Medicinal Chemistry. 2017, 139, 232-241

Characterization of Endogenous Sodium Channels in the ND7-23 Neuroblastoma Cell Line: Implications for Use as a Heterologous Ion Channel Expression System Suitable for Automated Patch Clamp Screening. Rogers, M.; Zidar, N.; Kikelj, D.; Kirby, R.W.  Assay and Drug Development Technologies. 2016, 14 (2),109-130 

Novel K⁺ Channel Targets in Atrial Fibrillation Drug Development – Where Are We? El-Haou, S.; Ford, J.; Milnes, J.  Journal of Cardiovascular Pharmacology. 2015, 66 (5), 412-431 

Atrial‐like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial‐selective pharmacology Devalla, H.D.; Schwach, V.; Ford, J.W.; Milnes, J.T.; El‐Haou, S.; Jackson, C.; Gkatzis, K.; Elliott, D.A.; de Sousa Lopes, S.M.C.; Mummery, C.L.; Verkerk, A.O.; Passier, R.  EMBO Molecular Medicine 2015. 7 (4), 394-410

Synthesis and biological evaluation of piperazine derivatives as novel isoform selective voltage-gated sodium (Nav) 1.3 channel modulators Jukič, M.; Frlan, R.; Chan, F.; Kirby, R.W.; Madge, D.J.; Tytgat, J.; Peigneur, S.; Anderluh, M.; Kikelj, D.  Medicinal Chemistry Research. 2015, 24 (6), 2366-2380

Open access to the KCNQ channel: Retigabine and second generation M-current openers. Chapter 10 in: Cox B & Gosling M (Eds.) Ion Channel Drug Discovery. Krupp, J.; Rush, A.M.; Swahn, B.; Main M. Royal Society of Chemistry Publishing. 2015, 238-257

Action of Clathrodin and Analogues on Voltage-Gated Sodium Channels Peigneur, S.; Žula, A.; Zidar, N.; Chan-Porter, F.; Kirby, R.; Madge, D.; Ilaš, J.; Kikelj, D.; Tytgat, J.  Marine Drugs. 2014, 12(4), 2132-43

Human Electrophysiological and Pharmacological Properties of XEN-D0101: A Novel Atrial-Selective Kv1.5/IKur Inhibitor. Ford J.; Milnes J.; Wettwer E.; Christ T.; Rogers M.; Sutton K.; Madge D.; Virag L.; Jost N.; Horvath Z.; Matschke K.; Varro A.; Ravens, U.  Journal of Cardiovascular Pharmacology. 2013, 61 (5), 408-415

Novel state-dependent voltage-gated sodium channel modulators, based on marine alkaloids from Agelas sponges Hodnik, Ž.; Tomašić, T.; Mašič L.P.; Chan, F.; Kirby, R.W.; Madge D.J.; Kikelj, D.  European Journal of Medicinal Chemistry. 2013, 70, 154-64

Ligand- and structure-based virtual screening for clathrodin-derived human voltage-gated sodium channel modulators Tomašić, T.; Hartzoulakis. B.; Zidar. N.; Chan, F.; Kirby R.W.; Madge, D.J.; Peigneur, S.; Tytgat, J.; Kikelj, D.  Journal of Chemical Information and Modelling. 2013, 53 (12), 3223-32

Recent advances in electrophysiology-based screening technology and the impact upon ion channel discovery research Southan, A.P.; Clark, G.  Methods in Molecular Biology. 2009, 565, 187-208

Voltage-clamp and current-clamp recordings from mammalian DRG neurons. Cummins, T.R.; Rush, A.M.;Estacion, M.; Dib-Hajj, S.D.; Waxman, S.G. Nature Protocols. 2009, 4, 1103-12

Multiple sodium channels and their roles in electrogenesis within dorsal root ganglion neurons. Rush, A.M.; Cummins, T.R.;  Waxman, S.G. Journal of Physiology. 2007, 579, 1-14

The role of sodium channels in neuropathic pain. Rogers, M.; Tang L.; Madge, D.; Stevens E.  Seminars in cell and developmental biology. 2006, 17 (5), 571-581

A single sodium channel mutation produces hyper- or hypoexcitability in different types of neurons. Rush, A.M.; Dib-Hajj, S.D.; Liu, S.; Cummins T.R.; Black, J.A.; Waxman, S.G. Proceedings of the National Academy of Science USA. 2006, 103, 8245-50